Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:16 PM
Ignite Modification Date:
2025-12-24 @ 11:16 PM
NCT ID:
NCT00162656
Eligibility Criteria:
Inclusion Criteria:
* Newly diagnosed B lineage non-Hodgkin's lymphoma with Revised European American Lymphoma (REAL) II 9 (diffuse large cell lymphoma), 10 (Burkitt's lymphoma), or 11 (high grade B cell lymphoma, Burkitt's like) or bone marrow \> 5% L3 blasts.
* Pre treatment imaging studies adequate to document Murphy disease stage
* Group B and C patients are eligible for randomization (Therapy stratification by group : Group A=completely resected stage I or completely resected abdominal stage II lesions, Group B= All cases not eligible for Group A or Group C, Group C= Any CNS involvement and/or bone marrow involvement ³ 25% blasts)
* Patients should be available for a minimum follow up of 36 months
* Informed consent prior to study entry
Exclusion Criteria:
* Anaplastic large cell Ki 1 positive lymphomas
* Previous chemotherapy.
* Congenital immunodeficiency
* Prior organ transplantation
* Previous malignancy of any type
* Known HIV positivity
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Months
Maximum Age:
20 Years
Study:
NCT00162656
Study Brief:
Protocol Section:
NCT00162656